ABSTRACT Objectives
INTRODUCTION
Rheumatoid arthritis (RA) is a chronic infl ammatory and destructive arthropathy that affects 1% of the population. 1 Patients with RA are at increased risk for premature cardiovascular (CV) events, which contributes greatly to their high mortality. 2 3 This elevated CV risk is independent of traditional risk factors and may be related to increased systemic infl ammation. Further, dyslipidaemia, characterised by elevated serum levels of total cholesterol (TC) and low-density lipoprotein (LDL) and decreased
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Mice expressing the KRN T-cell receptor (TCR) in the context of the major histocompatibility complex (MHC) Class II Allele I Ak (A g7 ) develop a spontaneous, erosive arthritis that resembles RA. 5 A g7 MHC class II alleles present endogenous glucose-6-phosphate isomerase (G6PI) peptides that are recognised by the KRN TCR. Innate and adaptive immune components including B cells, T cells, neutrophils, mast cells, macrophages, complement factors, infl ammatory cytokines and Fc receptors have been shown to be instrumental for the development of arthritis in these animals. [6] [7] [8] The arthritis is transferrable to naïve mice through injection of serum containing anti-G6PI antibodies, 9 with the resulting infl ammatory arthritis in recipient mice resembling the effector phase. K/BxA g7 mice also develop cardiac valvulitis, another feature occurring in RA. 10 Thus, the K/BxA g7 mouse represents an ideal animal model to examine the infl uence of infl ammatory arthritis on the development of atherosclerosis.
METHODS Animals
KRN mice (C57BL/6) were a gift from Drs Diane Mathis and Christophe Benoist. A g7 (C57BL/6) mice were provided by Dr Paul Allen. C57BL/6 (Jackson Laboratory, Bar Harbor, Maine, USA), and the NOD mice (Taconic, Germantown, New York, USA) were purchased. Genotyping was confi rmed by Transnetyx (Memphis, Tennessee, USA) and fl ow cytometry. Equal numbers of male and female mice were fed chow or Harlan Teklad atherogenic diet TD.94059 (Harlan, Houston, Texas, USA) containing 15.8% fat and 1.2% cholesterol. A subset of K/BxA g7 mice was injected subcutaneously with phosphate buffered saline (PBS) or 0.8 mg/kg etanercept twice weekly for 13 weeks. All studies were approved by the IACUC at Northwestern University, and mice were maintained within the Center for Comparative Medicine.
Scoring and induction of arthritis
Ankle width was measured using calipers. Clinical score (total=12) for four paws measured disease severity, scored as 0=normal, 1=swollen wrist/ ankle, 2=swelling extending to forepaw/hindpaw, 3=swelling extending to digits. Clinical damage index (total=40) for four paws was determined by summing the number of irreversibly hyper-extended or fl exed joints. Ankle joints were fi xed in 10% formalin and decalcifi ed. For the serum transfer-induced arthritis (STIA) experiments, C57BL/6 mice were injected intraperitoneally with 100 μl of K/BxN serum in 200 μl PBS.
Immunohistochemistry
Paraffi n-embedded ankle sections were stained with H&E. Paraffi n-embedded aortic sinus sections were stained with Masson's Trichrome, rat antimouse F4/80 (clone BM8), or rat antimouse CD45 (Caltag) antibodies. Imaging was performed using an Olympus DP40 microscope (Tokyo, Japan) equipped with a DP71 camera.
Evaluation of atherosclerosis
Peripheral blood was harvested by cardiac puncture, followed by ventricular perfusion with 20 ml of PBS. Aortas were excised, fi xed with 10% formalin, and stained with Sudan IV (SigmaAldrich, St Louis, Missouri, USA). Atherosclerosis was quantitated by computer-assisted morphometric analysis (ImagePro 6.3 software) of whole aortic (aortic root to iliac bifurcation) specimens. Results were expressed as the percentage of Sudan IV stained lesion area (calculated by Sudan IV stained area/total aortic area ×100).
Serum analysis
Serum cytokine and chemokine levels were assessed using Luminex-based (Austin, Texas, USA) 27-plex assays (Affymetrix, Santa Clara, California, USA) according to the manufacturer's instructions. Serum TC, low-density lipoprotein/very lowdensity lipoprotein (LDL/vLDL) and HDL levels were measured using enzymatic assays according to the manufacturer's instructions (AbCam, Cambridge, Massachusetts, USA).
Statistical analysis
Repeated-measure, two-way analysis of variance with Bonferroni post-tests were used for arthritis analyses. Student's t tests were used to compare Sudan IV staining, lipid and cytokine levels between groups. Linear regression analysis was used with TC, LDL/vLDL or HDL as X variable predictors, and atherosclerotic burden as the Y variable. Statistical signifi cance was established at p<0.05.
RESULTS

K/BxA g7 mice develop a severe, destructive arthropathy
In order to understand the interplay between systemic infl ammation that occurs in RA-like disease and atherosclerosis, we generated mice (K/BxA g7 ) that express the KRN TCR transgene (K), and the MHC class II Allele H-2k (A g7 ), which were backcrossed for several generations onto a C57BL/6 (H-2b) background. 11 While K/BxN mice 12 have been used extensively to model RA, the non-obese diabetic (NOD (N)) background, which predisposes K/BxN animals toward diabetes, may confound the atherosclerosis studies. At 4-5 weeks of age (fi gure 1A), K/BxA g7 mice developed a severe arthropathy, as measured by histologic ankle joint analysis (fi gure 1B), ankle width (fi gure 1C), clinical score (fi gure 1D) and damage index (fi gure 1E). In contrast, no arthritis was observed in control animals (C57BL/6) on a mixed H-2b and H-2k (A g7 ), or a pure H-2b background (unpublished data). There were also no gender differences identifi ed between mice. Our data suggest that K/BxA g7 mice develop a spontaneous, destructive arthritis that mimics RA, which is in agreement with previous fi ndings. 13 
K/BxA g7 mice are susceptible to atherosclerosis
Patients with RA are predisposed toward atherosclerotic disease. 2 3 To determine whether K/BxA g7 animals are susceptible to atherosclerosis, subgroups of mice were fed chow for 12 weeks followed by an atherogenic diet, or continued on the chow diet (fi gure 1A). K/BxA g7 mice displayed a 22-fold increase in aortic atherosclerosis compared with control mice, which exhibited negligible lesion formation even on an atherogenic diet (fi gures 2A,B). Further, plaque area was 2.3-fold greater in K/BxA g7 mice fed an atherogenic diet compared with chow (fi gures 2A,B). Gender-specifi c differences between mice were not observed. Leucocytes and macrophages were highly present in atherosclerotic plaques from K/BxA g7 mice (fi gure 2C), similar to RA patients. 14 These data suggest that K/BxA g7 arthritic/ atherosclerotic mice develop a histological and cellular plaque composition that is reminiscent of patients with RA. The K/BxN STIA model 9 resembles the effector phase of RA. Eighteen-week-old C57BL/6 mice were injected bimonthly with K/BxN serum, and were fed an atherogenic diet for 9 weeks (fi gures 3A-C). Atherosclerosis levels were 5.4-fold higher (p<0.001) in STIA mice than in controls fed an atherogenic diet (fi gures 3D,E). However, plaque area was still 4.1-fold greater in K/BxA g7 compared with STIA mice (fi gures 3D,E). Together, these data indicate that induction of infl ammatory arthritis via endogenous (K/BxA g7 ) or transferred (K/BxN) arthritogenic serum provokes the development of atherosclerosis. Furthermore, arthritis and atherosclerosis in the STIA model does not require specifi c T-cell receptors or MHC class II alleles.
K/BxA g7 mice are dyslipidaemic
Dyslipidaemia may be an important contributor to increased CV mortality in RA. 4 K/BxA g7 mice exhibited marked dyslipidaemia, characterised by reduced serum levels of TC (fi gure 4A, p<0.01), increased LDL/vLDL (fi gure 4B, p<0.01), and diminished HDL (fi gure 4C, p<0.01) compared with non-arthritic controls on an atherogenic diet. However, LDL/vLDL levels were increased by 3.2-fold (p<0.0001) in K/BxA g7 mice fed an atherogenic diet versus chow, while TC and HDL levels were unaffected by diet (fi gure 4). Lower HDL levels in K/BxA g7 mice were associated with greater amounts of atherosclerosis (R 2 =0.60, p<0.05, fi gure 3F) whereas, TC (fi gure 3D) and LDL/vLDL (fi gure 3E) were not signifi cantly related to atherosclerotic burden. Similar to K/BxA g7 mice, STIA mice demonstrated reduced levels of TC (fi gure 3A, p<0.01) and HDL (fi gure 3C, p<0.01), and elevated LDL/vLDL (fi gure 3B, p=0.12) compared with non-arthritic controls. Altogether, these fi ndings show that dyslipidaemia may contribute to the elevated atherosclerosis observed in K/BxA g7 mice, and that induction of arthritis elicits dyslipidaemia in normal animals.
Serum cytokines/chemokines are altered in K/BxA g7 mice
Cytokines, chemokines and adipokines are central to the development of atherosclerosis. 15 16 Serum levels of interleukin-6, sRANKL and CCL5 were signifi cantly greater (p<0.05), while KC and CCL-2 trended toward signifi cance in K/BxA g7 mice compared with C57BL/6 controls fed an atherogenic diet (fi gure 5A). Elevations in IL-21, IL-12/23 p40, tumour necrosis factor (TNFα), MIP-2, CXCL10 and GM-CSF were also detected, but were not signifi cant in K/BxA g7 mice compared with controls (online fi gure 1). In contrast, VEGF, TGF-β, IL-4, IL-13, IL-1α, IL-1β, IL-17A, G-CSF, CCL3, leptin and adiponectin were expressed at similar levels (fi gure 5B and online fi gure 1) and IL-10, interferon γ, IL-2, IL-12 p70 and IL-23 p19 were undetectable (unpublished data). Further, sRANKL, G-CSF, KC, CCL2 and CCL5 were increased in K/BxA g7 mice fed an atherogenic diet compared with chow (fi gure 5C), while levels of the remaining cytokines and chemokines were unaffected by diet (online fi gure 1). Together, these data suggest that higher levels of circulating cytokines and chemokines, but not adipokines, may contribute to increased atherosclerosis in K/BxA g7 mice.
TNF blockade improves arthritis and atherosclerosis in K/BxA g7 mice
Etanercept is a TNF antagonist commonly employed to treat RA. 17 controls. Atherosclerotic burden was reduced by 3.0-fold in etanercept-treated mice compared with controls (fi gure 6C). Further, etanercept therapy in K/BxA g7 mice reversed aortic valvulitis thickening (fi gure 3), 10 and impaired valvular function (online Videos 1-4). TC, LDL/vLDL and HDL levels were unaffected by etanercept treatment (fi gure 6D). Together, these data demonstrate a link between arthritis severity and the development of atherosclerosis in K/BxA g7 mice.
DISCUSSION
Here, we characterised K/BxA g7 mice as a unique model of arthritis/atherosclerosis that recapitulates the same sequence of events occurring in RA. Even passive transfer of arthritis triggers the development of atherosclerosis, suggesting that both disease states occur independently of the unique TCR (KRN) and MHC class II allele (A g7 ) present in K/BxA g7 mice. While previous studies have shown that mice lacking Fas 18 or FasL, 19 or that are on a genetically predisposed background (BWF1), 20 develop SLE-like disease and enhanced atherosclerosis when fed a high fat diet, we are the fi rst to generate a murine model of RA-like disease that is also susceptible to atherosclerosis. K/BxA g7 mice also develop dyslipidaemia, and display increased serum levels of pro-infl ammatory cytokines and chemokines. TNF blockade diminishes arthritis and atherosclerosis in K/BxA g7 mice. Collectively, these data link arthritis and atherosclerosis as interdependent disease processes, and establish the K/BxA g7 mouse as a unique model for preclinical testing of therapeutics for these disorders.
K/BxA g7 mice develop a destructive infl ammatory arthritis mirroring RA patients with severe or untreated disease. Unlike RA, there was no evidence of calcifi ed aortic lesions or thrombotic events despite extensive atherosclerosis in K/BxA g7 animals (unpublished data). Yet, K/BxA g7 mice demonstrated a lipid paradox (diminished TC and HDL) that resembles the dyslipidaemia seen in RA patients with the greatest infl ammatory burden. 21 There was a signifi cant inverse association between HDL levels and plaque area in K/BxA g7 mice, consistent with previous studies showing an atheroprotective role of HDL in RA. 4 However, treatment with etanercept improves arthritis and atherosclerosis without affecting lipid levels in K/BxA g7 mice, suggesting a non-causative relationship between dyslipidaemia and atherosclerosis in these animals. Future studies will determine whether altering dyslipidaemia impacts the development of atherosclerosis in K/BxA g7 mice.
Since cytokines and chemokines are potent orchestrators of infl ammation, altered levels of these factors may contribute to the development of arthritis and vascular disease in K/BxA g7 mice. Indeed, elevated levels of several infl ammatory mediators were evident in K/BxA g7 mice and TNF blockade led to improved arthritis and atherosclerosis. However, epidemiologic studies have yielded confl icting data on the effects of diseasemodifying treatments on RA disease activity and CV disease. Thus, dissecting the disease-specifi c effects of individual mediators will be critical to understanding the relationships among infl ammatory arthritis, dyslipidaemia and atherosclerosis in K/ BxA g7 mice as a model for RA-like disease.
